U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Diltiazem Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 02/21/2018
»Therapeutic Categories: Cardiovascular

Expand all

Akorn Pharmaceuticals (Revised 04/08/2022)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10) On allocation, then discontinued. Discontinuation of the manufacture of the drug
Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25) Discontinued Discontinuation of the manufacture of the drug
Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26) Discontinued Discontinuation of the manufacture of the drug
Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05) Discontinued Discontinuation of the manufacture of the drug

Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 09/28/2022)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/5mL vial (NDC 70860-301-05) On allocation
50 mg/10mL vial (NDC 70860-301-10) Available
125 mg/25mL vial (NDC 70860-301-25) Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 08/26/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/mL, 5 mL vial (NDC 0641-6013-10) Inventory is currently available Demand increase for the drug
5 mg/mL, 10 mL vial (NDC 0641-6014-10) Inventory is currently available Demand increase for the drug
5 mg/mL, 30 mL vial (NDC 0641-6015-10) Inventory is currently available Demand increase for the drug

Hospira, Inc. (Revised 09/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03) Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-02) Discontinued Discontinuation of the manufacture of the drug
Back to Top